HKSE - Delayed Quote HKD
TOT BIOPHARM-B (1875.HK)
2.050
+0.230
+(12.64%)
At close: 4:08:09 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
56,431
56,431
59,929
-175,137
-263,116
Investing Cash Flow
-164,105
-164,105
-282,764
-108,393
12,526
Financing Cash Flow
38,225
38,225
481,240
212,082
-61,707
End Cash Position
351,600
351,600
417,769
152,805
225,533
Capital Expenditure
-203,200
-203,200
-240,123
-115,313
-22,181
Issuance of Capital Stock
--
--
405,788
1,990
--
Issuance of Debt
132,152
132,152
277,858
205,966
--
Repayment of Debt
-75,500
-75,500
-196,191
--
-60,000
Free Cash Flow
-146,769
-146,769
-180,194
-290,450
-285,297
12/31/2020 - 11/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
688382.SS InventisBio Co., Limited
22.41
+2.05%
2126.HK JW (Cayman) Therapeutics Co. Ltd
1.610
-1.23%
1167.HK JACOBIO-B
3.900
+5.41%
ESLA Estrella Immunopharma, Inc.
0.9300
-3.12%
IUGNF Imugene Limited
0.0200
0.00%
ADAG Adagene Inc.
1.3900
-2.80%
9606.HK Duality Biotherapeutics, Inc.
225.000
+2.93%
CASI CASI Pharmaceuticals, Inc.
2.0300
+4.64%
CRGX CARGO Therapeutics, Inc.
4.4900
-1.32%
0775.HK CKLIFE SCIENCES
0.840
0.00%